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ABSTRACT 
Nrf2 is a kind of transcription factor which is related to antioxidative enzyme synthesis and protecting cell from aging 
process. Keap1 protein receptor, which acts as a suppressor specifically interacts with Nrf2. Abrogating the interaction 
between Keap1 and Nrf2 will activate Nrf2 in the cytosol. One of the compound which is suggested as an inhibitor of Keap1- 
Nrf2 interaction is curcumin. Therefore, this research aims to identify potency of curcumin as antioxidant and an inhibitor in 
the interaction of Keap1-Nrf2 in order to activate Nrf2. The biological activity prediction of curcumin was analyzed by PASS 
online server. Then, docking process of curcumin to Keap1 was carried out by Pyrx AutoDock Vina to analyze the binding 
affinity and compared to Keap1-IQK as a control. Results showed that curcumin has a high ability as an antioxidant and free 
radical scavenger with Pa score 0.634, and 0.771, respectively. Furthermore, docking process pointed out that IQK had -10.7 
Kcal/mol in binding affinity and it was higher than the binding affinity of curcumin about -8.4 Kcal/mol. However, it is 
suggested that curcumin has the high potential as antioxidant and inhibitor to release Keap1-Nrf2 complex. 
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INTRODUCTION 
 
Curcumin is an herbal compound which is derived from 
Curcuma longa rhizome. It is not only antioxidant but also 
acts as an electrophilic compound which can trigger the 
Nrf2/ARE signaling pathway to activate the antioxidative 
enzyme (Sikora et al., 2010; Shen et al., 2012). The diet of 
mice treated with 0.2% tetrahydro curcumin at the age of 13 
months had significantly longer average lifespan about 
11.7% (Kitani et al., 2007). In another study, curcumin also 
increased the lifespan of Drosophila sp. (Shen et al., 2012). 
Curcumin commonly used as preventing the disease related 
to aging issue (Sikora et al., 2010). Curcumin induces 
antioxidant defense by modulating Nrf2. When, curcumin 
interact with Keap1, Nrf2 is released and translocated into 
the nucleus where it binds to an antioxidant responsive 
element in DNA to initiate gene expression of an antioxidant 
enzyme. That enzyme will reduce free radicals and protect 
the cell from ROS (Gonzalez-Reyes et al., 2013). 
Nowadays, the application of computational or in silico 
approach has been widely applied for pharmacological 
studies. Such methods were developed to discover novel 
molecules which potentially activated protein target (Ekins 
et al., 2007). Docking process is one kind of analysis in 
order to f ind small molecules with desired function 
(Dallakyan et al., 2015). Then, the potential of small 
molecules can be analyzed based on the biological activity 
prediction by PASS server. It is indicated by Pa (probability 
activity) and Pi (probability inactivity) score which varies 
from 0 to 1. The positive result is determined if Pa is higher 
than Pi (Paramashivam et al., 2015). Therefore, this study 
aims to investigate the potential of curcumin as an 
antioxidant to activate Nrf2 by inhibiting KEAP1-Nrf2 
interaction using in silico approach. 
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MATERIAL AND METHODS 
Ligand preparation: The 3D structure of Curcumin (CID: 
969516) was retrieved from PubChem (www.pubchem.ncbi. 
nlm.nih.gov) in SDF format (Figure 1). Furthermore, it was 
converted by Open Babel to PDB format for docking 
preparation. 
 
Figure 1: Two and Three-dimensional structure of curcumin Figure 2: Prepared model of Keap1 as protein target 
 
Biological activity analysis: Biological activity includes 
potential of antioxidant and free radical scavenger of 
curcumin were predicted by PASS server (http:// 
www.pharmaexpert.ru/passonline/index.php). It is indicated 
by Pa (Probability activity) score. 
Accession of target protein: The 3D structure of protein 
receptor Keap1 (PDBID: 4IQK) which binds to IQK ligand 
was collected from Protein Data Bank (PDB) (www.rscb.org/ 
pdb/home/home.do). It was opened by PyMol to separate 
from the ligand and another water molecule. This 
optimization was essential for docking preparation 
(Figure 2). 
Molecular docking analysis: Curcumin was docked to 
Keap1 receptor in a specific site similar to IQK as ligand 
(SAR). It is determined by score of Pa (probability activity) 
and Pi (probability inactivity) with values varing from 0 to 
1 (Paramashivam et al., 2015). Curcumin was analyzed in 
order to find out the possible biological activity of 
antioxidant and free radical scavenger. The analysis shows 
that curcumin obviously determines as free radical scavenger 
which is indicated by Pa score 0.771. Moreover, curcumin 
was also highly potential as an antioxidant agent with Pa 
score of 0.634 (Table 1). Curcumin was proved to be as 
antioxidant and free radical scavenger. Moreever, curcumin 
inhibit the DNA damage, protein denaturation and lipid 
peroxidation. (Savcun et al., 2013; Menon et al., 2007). 
 
Table 1: Biological activity prediction of curcumin 
 
  
Biological Activity Probability Activity (Pa) 
reference. Docking process was carried out by Pyrx AutoDock AntioxidantFree radical scavenger 0.634 
Vina. It was aimed to calculate binding affinity score of the 
curcumin-Keap1 complex. 
 0.771 
Molecular interaction analysis: The molecular interaction 
was analyzed by Lig and Scout to visualize and identify 
interaction residues in the binding domain of curcumin and 
Keap1 receptor. Potential inhibition of curcumin was 
indicated by molecular interaction of Keap1 which interacts 
to curcumin. 
 
RESULTSAND DISCUSSION 
 
The biological activity of the herbal compound was analyzed 
by PASS online server with Structure Activity Relationship 
Those Pa and Pi scores considered to be measurement 
tools to predict active or inactive compound respectively. 
The minimum standard of reliable value is 0.3. Biological 
activity with Pa > 0.7 indicates that the result of in silico 
assay will be relatively similar to laboratory assay, while Pa 
> 0.3 indicates that those compounds are potentially in silico 
approach (Benchabane et al., 2009). 
Molecular Docking as further analysis was used to 
evaluate the potential of curcumin as Keap1 inhibitor. 
Docking process was conducted on the active site of Keap1 
receptors which bind to IQK ligand. IQK is a reference 
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inhibitor used as a control for comparison to curcumin. It 
utilizes to investigate the potential of curcumin to inhibit 
the interaction of Keap1 and Nrf2. 
Nrf2 (NF-E2-Related Factor 2) is a transcription factor 
which interacts to its specific repressor, Keap1 (Motohashi 
et al., 2004). Nrf2 in responding to cytotoxic stress is well 
defined. The main role of Nrf2 is involved in oxidative stress 
response and aging issue. Nrf2 degradation is initiated by 
Keap1 interaction. (Bruns et al., 2015). 
Based on Table 2, the results pointed out that IQK 
efficiently inhibited Keap1 receptor with minimum binding 
affinity score about -10.7 Kcal/mol that compared to 
curcumin which only had -8.4 kcal/mol. However, it suggests 
that curcumin potentially acts as an inhibitor of Keap1 
because it also has a binding affinity score which is relatively 
low. In addition, the result of docking process also showed 
molecular interaction while curcumin binds to substrate 
binding domain of Keap1 in the SER508A, ALA556A, 
 
 
Figure 3: Molecular interaction of curcumin with Keap1 protein receptor (blue) on substrate binding domain (SER508A, ALA556A, 
TYR525A, TYR334A and ARG415A) 
Figure 4: Mechanism of Keap1 inhibition for activating Nrf2 (Jockers et al., 2016) 
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Table 2: Binding affinity score of IQK and curcumin to Keap1 
receptor 
 
  
Protein receptor Ligand Binding affinity 
(Kcal/mol) 
 
  
Keap1(PDBID: 4IQK)        IQK -10.7 
Curcumin -8.4 
 
  
 
TYR525A, TYR334A and ARG415A (Figure 3). It indicated 
that curcumin could act as IQK when inhibit the Keap1 
protein in the substrate binding domain. 
For inhibiting aging process, curcumin activates Nrf2 
which is already in the cytoplasm and remain bound to Keap1 
receptor. Curcumin interacts to Keap1, Nrf2 is released and 
is translocated into nucleus where it binds to an antioxidant 
responsive element in DNA to initiate gene expression. Nrf2- 
regulated gene classified into phase II xenobiotic- 
metabolizing, an antioxidant enzyme, DNA repair enzymes 
and anti-inflammatory enzyme (Figure 4) (Jockers et al., 
2016). That enzyme will reduce free radicals and protect the 
cell from ROS for increasing the ability of the cell to repair 
(Gonzalez-Reyes et al., 2013). 
 
CONCLUSION 
 
It could be concluded that curcumin has highly biological 
activity as an antioxidant and free radical scavenger in the 
computational study. Moreover, curcumin also strongly 
binding to the active site of Keap1 and interact to the 
substrate binding domain of Keap1 in SER508A, ALA556A, 
TYR525A, TYR334A and ARG415A. It suggested that 
curcumin is highly potential as an inhibitor of Keap1 to 
activate for Nrf2 protein. 
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